Niki BioSolutions NIKI
NASDAQ NIKI
$1.83 -0.03 (-1.61%)
At close: Oct 23, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Amortization of Deferred Charges (2024 - 2025)

Updated

Analysis

Niki BioSolutions (NIKI) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Niki BioSolutions 997,917.32 757,602.32 -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 15,459.00
Nov 30, 2024 12,276.00
Aug 31, 2024 12,694.00
API Access

Niki BioSolutions Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=NIKI&period=max&api_key=YOUR_API_KEY